Vitamin D and Serum Cytokines in a Randomized Clinical Trial
Open Access
- 1 January 2010
- journal article
- research article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2010, 1-7
- https://doi.org/10.1155/2010/305054
Abstract
Background. The role of vitamin D in the body's ability to fight influenza and URI's may be dependent on regulation of specific cytokines that participate in the host inflammatory response. The aim of this study was to test the hypothesis that vitamin D can influence intracellular signaling to regulate the production of cytokines.Subjects and Methods. This study was a 3-month prospective placebo-controlled trial of vitamin D3 supplementation in ambulatory adults [Li-Ng et al., 2009]. 162 volunteers were randomized to receive either 50 (2000 IU) of vitamin D3 or matching placebo. 25(OH)D and the levels of 10 different cytokines (IL-2, 4, 5, 6, 8, 10, 13, GM-CSF, IFN-, TNF-) were measured in the serum of participants at baseline and the final visit. There were 6 drop-outs from the active vitamin D group and 8 from the placebo group.Results. In the active vitamin D group, we found a significant median percent decline in levels of GM-CSF (−62.9%,), IFN-(−38.9%,), IL-4 (−50.8%,), IL-8 (−48.4%,), and IL-10 (−70.4%,. In the placebo group, there were significant declines for GM-CSF (−53.2%,) and IFN-(−34.4%,). For each cytokine, there was no significant difference in the rate of decline between the two groups. 25(OH)D levels increased in the active vitamin D group from a mean of nmol/L to nmol/L.Conclusions. The present study did not show that vitamin D3 supplementation changed circulating cytokine levels among healthy adults.
Keywords
Funding Information
- Empire Clinical Research Investigator Program
This publication has 32 references indexed in Scilit:
- Vitamin D and Innate ImmunityClinical Reviews in Bone and Mineral Metabolism, 2009
- Prevalence of Hypovitaminosis D in Cardiovascular Diseases (from the National Health and Nutrition Examination Survey 2001 to 2004)The American Journal of Cardiology, 2008
- 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General PopulationArchives of Internal Medicine, 2008
- Vitamin D in rheumatoid arthritisAutoimmunity Reviews, 2007
- Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trialThe American Journal of Clinical Nutrition, 2007
- Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene ExpressionThe Journal of Immunology, 2004
- Low Vitamin D and High Parathyroid Hormone Levels as Determinants of Loss of Muscle Strength and Muscle Mass (Sarcopenia): The Longitudinal Aging Study AmsterdamJournal of Clinical Endocrinology & Metabolism, 2003
- Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control studyOccupational and Environmental Medicine, 2002
- Intake of vitamin D and risk of type 1 diabetes: a birth-cohort studyThe Lancet, 2001